SCP-9547
Unknown
?
low confidence
SCP-9547
Expected annual
$23.0M
One-time setup
$31.4M
Annual recurring
$22.9M
Personnel
20
One-time capital and R&D outlays are estimated at tens of millions for test development, secure storage and facility upgrades; recurring annual costs are dominated by staffing, specialist testing, rapid-response teams, surveillance and ongoing clinical research (~$22.9M/yr). Main drivers: R&D/clinical programs, specialist testing, rapid-response operations and global surveillance.
One-Time Capital Costs
Total: $31.4M
Annual Recurring Costs
Total: $22.9M/yr
Cost Scenarios
📊
Baseline
(baseline)
$22.9M/yr
Normal year with routine testing, maintenance, research and no major incidents.
routine_onboarding_testing
scheduled_specialist_tests
regular_surveillance
🚨
Minor Incident
$24.6M/yr
Localized exposure or cluster requiring targeted mobilization, surge testing and small cover-up/legal action.
localized_cluster
targeted_MTF_mobilization
surge_testing
🚨
Major Breach
$32.9M/yr
Widespread discovery or exposure in a Nexus/Free Port requiring mass mobilization, mass-testing and large-scale containment and cover-up.
mass_exposure
large_scale_MTF_and_medical_mobilization
major_cover_up_and_liability_payouts
Personnel
20 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist | 8 | [#7] Assay development, validation, and clinical research leadership. |
| Laboratory Technician | 6 | [#7] Routine kit processing, QA/QC, sample handling and containment operations. |
| Clinical / Occupational Physician | 2 | [#7, #12] Medical monitoring, treatment protocols and surveillance of affected personnel. |
| Containment Officer / MTF Agent | 2 | [#8] Rapid-response and extraction support for field incidents. |
| Engineer / Maintenance | 1 | [#6, #9] Maintain specialized HVAC, decon systems and containment infrastructure. |
| Administrative Staff | 1 | [#13] Records, database administration, scheduling and compliance coordination. |
Confidence Notes
Estimates aggregate wide, analyst-provided ranges and depend heavily on policy choices (testing scope, allowance of live exposures, global coverage). Large uncertainty in frequency of specialist tests and required number of upgraded facilities leads to low confidence.